⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25252928 | 1.00 | — | — | |
| SCHEMBL20266441 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL3512346 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL28781228 | 0.97 | — | — | |
| Fluoride SCHEMBL10649196 | 0.85 | — | — | |
| SCHEMBL226121 | 0.85 | — | — | |
| SCHEMBL226122 | 0.85 | — | — | |
| SCHEMBL31558 | 0.85 | — | — | |
| Hydrochloric Acid SCHEMBL3992750 | 0.83 | — | — | |
| Hydrochloric Acid SCHEMBL313844 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 479 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12540126-B2 | Method for preparing oxetan-2-ylmethanamine | ACCELA CHEMBIO CO., LTD. (CN) | 2026-02-03 | — | — | US | claimed |
| CN-115991685-B | Preparation method of oxetane-2-methylamine | 韶远科技（上海)有限公司 | 2025-03-04 | — | — | CN | claimed |
| US-20240317695-A1 | METHOD FOR PREPARING OXETAN-2-YLMETHANAMINE | ACCELA CHEMBIO CO., LTD. (CN) | 2024-09-26 | — | — | US | claimed |
| EP-4194446-A1 | PREPARATION METHOD FOR OXETANE-2-METHYLAMINE | ACCELA CHEMBIO CO., LTD. (CN) | 2023-06-14 | — | — | EP | claimed |
| WO-2023065434-A1 | PREPARATION METHOD FOR OXETANE-2-METHYLAMINE | 韶远科技（上海)有限公司 | 2023-04-27 | — | — | WO | claimed |
| CN-115991685-A | Preparation method of oxetane-2-methylamine | 韶远科技（上海)有限公司 | 2023-04-21 | — | — | CN | claimed |
| US-RE49481-E1 | Compounds for the treatment and prophylaxis of respiratory syncytial virus disease | HOFFMANN-LA ROCHE INC. (US) | 2023-04-04 | — | — | US | claimed |
| EP-3436017-B1 | PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA | MERCK SHARP & DOHME (US) | 2020-09-23 | — | — | EP | claimed |
| US-10544147-B2 | Purine inhibitors of human phosphatidylinositol 3-kinase delta | MERCK SHARP & DOHME CORP. (US) | 2020-01-28 | — | — | US | claimed |
| US-20190119278-A1 | Purine Inhibitors of Human Phosphatidylinositol 3-Kinase Delta | MERCK SHARP & DOHME CORP. (US) | 2019-04-25 | — | — | US | claimed |
| US-8962608-B2 | Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors | MERCK SHARP & DOHME CORP. (US) | 2015-02-24 | — | — | US | claimed |
| US-8871756-B2 | Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease | HOFFMANN-LA ROCHE INC. (US) | 2014-10-28 | — | — | US | claimed |
| US-20140243309-A1 | CYCLOALKYLNITRILE PYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME LLC | 2014-08-28 | — | — | US | claimed |
| EP-2766370-A1 | COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE | F.HOFFMANN-LA ROCHE AG (CH) | 2014-08-20 | — | — | EP | claimed |
| EP-2742039-A1 | COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE | F. Hoffmann-La Roche AG (CH) | 2014-06-18 | — | — | EP | claimed |
| US-8604019-B2 | Compounds for the treatment and prophylaxis of respiratory syncytial virus disease | HOFFMANN-LA ROCHE INC. (US) | 2013-12-10 | — | — | US | claimed |
| US-20130196974-A1 | COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE | HOFFMANN-LA ROCHE INC. | 2013-08-01 | — | — | US | claimed |
| WO-2013053658-A1 | COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE | F. HOFFMANN-LA ROCHE AG (CH) | 2013-04-18 | — | — | WO | claimed |
| US-20130090328-A1 | COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE | Hoffmann-La Roche Inc (US) | 2013-04-11 | — | — | US | claimed |
| WO-2013020993-A1 | COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE | F. HOFFMANN-LA ROCHE AG (CH) | 2013-02-14 | — | — | WO | claimed |